Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N L Benowitz

Showing results (61-70 of 291) with videos related to

Pageof 30
Sort By:
Medical Toxicology and Adverse Drug Experience|November 1, 1989
Poisoning due to class 1B antiarrhythmic drugs. Lignocaine, mexiletine and tocainideC P Denaro, N L Benowitz
Clinical Pharmacology and Therapeutics|January 1, 1990
Pharmacoepidemiology of the effect of caffeine on blood pressureD S Sharp, N L Benowitz
Emergency Medicine Clinics of North America|August 1, 1984
Environmental and drug-induced hyperthermia. Pathophysiology, recognition, and managementK R Olson, N L Benowitz
Drugs & Aging|July 1, 1996
The benefits of stopping smoking and the role of nicotine replacement therapy in older patientsS G Gourlay, N L Benowitz
Medical Toxicology|March 1, 1986
Tricyclic antidepressant poisoning. Management of arrhythmiasP R Pentel, N L Benowitz
Clinics in Chest Medicine|December 1, 1991
Basic and clinical psychopharmacology of nicotineJ Le Houezec, N L Benowitz
Archives of Internal Medicine|October 1, 1992
Orthostatic hypotension in ciguatera fish poisoningR J Geller, N L Benowitz
Pharmacology, Biochemistry, and Behavior|November 1, 1989
Caffeine and cigarette smoking: behavioral, cardiovascular, and metabolic interactionsC R Brown, N L Benowitz
Journal of Clinical Pharmacology|September 1, 1992
Workshop on problem-based learning as a method for teaching clinical pharmacology and therapeutics in medical schoolR E Vestal, N L Benowitz
Clinical Pharmacology and Therapeutics|September 1, 1975
Cardiovascular effects of prolonged delta-9-tetrahydrocannabinol ingestionN L Benowitz, R T Jones
Pageof 30

Showing results (61-70 of 291) with videos related to

Sort By:
Pageof 30
Medical Toxicology and Adverse Drug Experience|November 1, 1989
Poisoning due to class 1B antiarrhythmic drugs. Lignocaine, mexiletine and tocainideC P Denaro, N L Benowitz
Clinical Pharmacology and Therapeutics|January 1, 1990
Pharmacoepidemiology of the effect of caffeine on blood pressureD S Sharp, N L Benowitz
Emergency Medicine Clinics of North America|August 1, 1984
Environmental and drug-induced hyperthermia. Pathophysiology, recognition, and managementK R Olson, N L Benowitz
Drugs & Aging|July 1, 1996
The benefits of stopping smoking and the role of nicotine replacement therapy in older patientsS G Gourlay, N L Benowitz
Medical Toxicology|March 1, 1986
Tricyclic antidepressant poisoning. Management of arrhythmiasP R Pentel, N L Benowitz
Clinics in Chest Medicine|December 1, 1991
Basic and clinical psychopharmacology of nicotineJ Le Houezec, N L Benowitz
Archives of Internal Medicine|October 1, 1992
Orthostatic hypotension in ciguatera fish poisoningR J Geller, N L Benowitz
Pharmacology, Biochemistry, and Behavior|November 1, 1989
Caffeine and cigarette smoking: behavioral, cardiovascular, and metabolic interactionsC R Brown, N L Benowitz
Journal of Clinical Pharmacology|September 1, 1992
Workshop on problem-based learning as a method for teaching clinical pharmacology and therapeutics in medical schoolR E Vestal, N L Benowitz
Clinical Pharmacology and Therapeutics|September 1, 1975
Cardiovascular effects of prolonged delta-9-tetrahydrocannabinol ingestionN L Benowitz, R T Jones
Pageof 30